Clinical Trial Update: Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Tenofovir alafenamide to Tenofovir disoproxil fumarate for treating hepatitis B in HBeAg-negative chronic hepatitis B patients in China;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Vemlidy (tenofovir alafenamide)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: HBV, Chronic HBV Infection | Phase 3 | Status: COMPLETED | Results posted: 2018-04-18